121 related articles for article (PubMed ID: 24376921)
1. Two-dimensional imaging of tumour control probabilities and normal tissue complication probabilities.
Szlag M; Slosarek K
Rep Pract Oncol Radiother; 2010; 15(2):31-9. PubMed ID: 24376921
[TBL] [Abstract][Full Text] [Related]
2. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of an indigenous, radiobiological model-based tumor control probability and normal tissue complication probability estimation software for routine plan evaluation in clinics.
Patel G; Mandal A; Bharati A; Choudhary S; Mishra R; Mourya A
J Cancer Res Ther; 2022; 18(6):1697-1705. PubMed ID: 36412432
[TBL] [Abstract][Full Text] [Related]
4. Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer.
Sukhikh ES; Sukhikh LG; Taletsky AV; Vertinsky AV; Izhevsky PV; Sheino IN
Phys Med; 2019 Jun; 62():41-46. PubMed ID: 31153397
[TBL] [Abstract][Full Text] [Related]
5. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
[TBL] [Abstract][Full Text] [Related]
6. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
[TBL] [Abstract][Full Text] [Related]
7. A method to visualize the uncertainty of the prediction of radiobiological models.
Zhang L; Hub M; Thieke C; Floca RO; Karger CP
Phys Med; 2013 Sep; 29(5):556-61. PubMed ID: 23260766
[TBL] [Abstract][Full Text] [Related]
8. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
Paganetti H
Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
[TBL] [Abstract][Full Text] [Related]
9. [Construction of radiobiological models as TCP (tumor control probability) and NTCP (normal tissue complication probability): from dose to clinical effects prediction].
Chaikh A; Thariat J; Thureau S; Tessonnier T; Kammerer E; Fontbonne C; Dubray B; Balosso J; Fontbonne JM
Cancer Radiother; 2020 Jun; 24(3):247-257. PubMed ID: 32220563
[TBL] [Abstract][Full Text] [Related]
10. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
[TBL] [Abstract][Full Text] [Related]
11. On the radiobiological impact of metal artifacts in head-and-neck IMRT in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Kim Y; Tomé WA
Med Biol Eng Comput; 2007 Nov; 45(11):1045-51. PubMed ID: 17574487
[TBL] [Abstract][Full Text] [Related]
12. "SABER": A new software tool for radiotherapy treatment plan evaluation.
Zhao B; Joiner MC; Orton CG; Burmeister J
Med Phys; 2010 Nov; 37(11):5586-92. PubMed ID: 21158270
[TBL] [Abstract][Full Text] [Related]
13. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.
Fiorino C; Broggi S; Corletto D; Cattaneo GM; Calandrino R
Radiother Oncol; 2000 Apr; 55(1):49-58. PubMed ID: 10788688
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
15. Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index.
Chaikh A; Balosso J
Transl Lung Cancer Res; 2016 Jun; 5(3):265-71. PubMed ID: 27413708
[TBL] [Abstract][Full Text] [Related]
16. The effect of slice thickness on target and organs at risk volumes, dosimetric coverage and radiobiological impact in IMRT planning.
Srivastava SP; Cheng CW; Das IJ
Clin Transl Oncol; 2016 May; 18(5):469-79. PubMed ID: 26311077
[TBL] [Abstract][Full Text] [Related]
17. Integration of radiobiological modeling and indices in comparative plan evaluation: A study comparing VMAT and 3D-CRT in patients with NSCLC.
Roy S; Badragan I; Ahmed SN; Sia M; Singh J; Bahl G
Pract Radiat Oncol; 2018; 8(5):e355-e363. PubMed ID: 29703705
[TBL] [Abstract][Full Text] [Related]
18. Novel Radiobiological Gamma Index for Evaluation of 3-Dimensional Predicted Dose Distribution.
Sumida I; Yamaguchi H; Kizaki H; Aboshi K; Tsujii M; Yoshikawa N; Yamada Y; Suzuki O; Seo Y; Isohashi F; Yoshioka Y; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):779-86. PubMed ID: 25936816
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
20. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
